Both insulin infusion with subsequent hypoglycemia and the euglycemic clamp cause a ghrelin decrease, indicating the main regulator role of hyperinsulinemia, rather than hyperglycemia, on ghrelin [119,120]. The gene discussed is INS; the disease is Hyperglycemia.